VeriStat White Papers

1. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

   Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

2. Successful Preparation Strategies For NDA/MAA Marketing Applications 4/28/2021

   No two new drug applications (NDAs) or marketing authorization applications (MAAs) are the same. Learn the key strategies that can be implemented to propel even the most complex submissions to successful regulatory conclusions.